General
Preferred name
TMS
Synonyms
(E)-2,3',4,5'-tetramethoxystilbene ()
2,3',4,5'-Tetramethoxystilbene ()
P&D ID
PD021493
CAS
24144-92-1
Tags
available
probe
Probe info
Probe type
P&D approved
calculated probe
Probe selectivity
protein-selective
Probe targets
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION 2,3',4,5'-Tetramethoxystilbene (TMS) is a selective and competitive CYP1B1 inhibitor. It is a resveratrol derivative. (GtoPdb)
DESCRIPTION TMS ((E)-2,3',4,5'-tetramethoxystilbene) is a selective and competitive CYP1B1 inhibitor with an IC50 of 6 nM and a Ki value of 3 nM. TMS shows a lesser extent inhibitory effect on CYP1A1 (IC50=300 nM) and CYP1A2 (IC50=3.1 ¦ÌM). TMS is a methylated derivative of resveratrol and has anti-cancer activity[1][2][3].
PRICE 53
DESCRIPTION Cytochrome P450 1B1 inhibitor (Tocriscreen Plus)
DESCRIPTION Cytochrome P450 1B1 inhibitor (Tocriscreen Total)
DESCRIPTION TMS (2,3',4,5'-Tetramethoxystilbene) is a very selective and potent competitive inhibitor of P450 1B1 (CYP1A1). (TargetMol Bioactive Compound Library)
Cell lines
1
Organisms
0
Compound Sets
12
Axon Medchem Screening Library
Cayman Chemical Bioactives
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
MedChem Express Bioactive Compound Library
Probe Miner (suitable probes)
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
External IDs
17
Properties
(calculated by RDKit )
Molecular Weight
300.14
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
6
Ring Count
2
Aromatic Ring Count
2
cLogP
3.89
TPSA
36.92
Fraction CSP3
0.22
Chiral centers
0.0
Largest ring
6.0
QED
0.76
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Enzymes
Target
CYP450 1B1
Cytochrome P450
CYP1B1 inhibitor
P450 (e.g. CYP17)
Pathway
Metabolic Enzyme/Protease
Metabolism
Source data